These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth. Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069 [TBL] [Abstract][Full Text] [Related]
13. Stable expression of human tartrate-resistant acid phosphatase isoforms by CHO cells. Janckila AJ; Parthasarathy RN; Parthasarathy LK; Seelan RS; Yam LT Clin Chim Acta; 2002 Dec; 326(1-2):113-22. PubMed ID: 12417102 [TBL] [Abstract][Full Text] [Related]
14. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688 [TBL] [Abstract][Full Text] [Related]
15. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156 [TBL] [Abstract][Full Text] [Related]
18. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese. Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223 [TBL] [Abstract][Full Text] [Related]
19. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190 [TBL] [Abstract][Full Text] [Related]
20. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients. Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]